Intra-Cellular

[anonymous]

I agree. Some of us have been in this process for quite sometime. Was told a few times that my salary requirements weren’t a problem. Then the offer comes in $10k less and won’t negotiate.
If the fleet choices are bottom of the barrel, that may be the tipping point for me to just stay where I am come next next year.

 

[anonymous]

Any updates for those who are interviewing for a position where the manager has not officially been placed yet? Do you think we will have to wait until after the Dec 27th PDUFA date to know if the manager who interviewed us will move us forward?

 

[anonymous]

Just heard from a very reliable source that the phone screens being done right now for remaining openings are with managers "going through the motions" for HR/Legal reasons. Apparently these remaining jobs have already been offered and accepted and the phone screens at this stage of the process are bogus. The hiring managers just covering their ass in case their asked if they have done their due diligence with candidate screening. Just wrong!!!

I think you misunderstood.

 

[anonymous]

This company is really going to botch a launch over pennies? A team of backup candidates and people backing out pre-launch, mid- launch, 6 months into launch? Who is the idiot who thought up this no negotiations strategy?

I didn’t even get what I “put on my sheet” for my “requirement”. Thanks for the couple months free pay though. You’d be better off lowballing people and letting them negotiate. You’d end up saving money and reps savvy enough to negotiate would feel like they won

 

[anonymous]

Would like to gain more insight about the points brought up: salary negotiation; bonus paid for losses at previous company; vacation negotiation, etc. from those who receive offers in wave 1 hiring. For those w/o managers yet, the hiring won’t occur until February. Thank you!

 

[anonymous]

Any updates for those who are interviewing for a position where the manager has not officially been placed yet? Do you think we will have to wait until after the Dec 27th PDUFA date to know if the manager who interviewed us will move us forward?

Recruiter is frustrated. Some regionals doing interviews for districts where managers don't start until January. Some are not. WTF?

 

[anonymous]

Recruiter is frustrated. Some regionals doing interviews for districts where managers don't start until January. Some are not. WTF?

Yes, I know people are currently interviewing for positions where the hiring manager has unofficially accepted the position but technically can not interview yet so they are interviewing with the RBM of another region who supposedly will thin out the candidates done before deciding who will be moved forward to the actual manager after the PDUFA date. I think they are doing it in waves bc there were obviously less managers hired in the first wave than there will be in the second wave after Dec 27th.

 

[anonymous]

Was talking to a peer at a different organization than me about this role. We both think 007 and the PDE sound interesting from a clinical and promotional perspective. Especially if 007 can have any appreciable affect on glutamate.

Then foolishly and in a moment of complete mental collapse I came to CafePharma.
And after totally pissing away 30 min of my life reading these posts let me ask all you conspiracy theorists and excessively “talented” folks a question:

What do you think would happen to the company (leadership, board, investors, stakeholders, etc) if ANY of your theories got out and the launch of the companies flagship molecule was botched?

Take your time. It’s a thinker....

 

[anonymous]

Was talking to a peer at a different organization than me about this role. We both think 007 and the PDE sound interesting from a clinical and promotional perspective. Especially if 007 can have any appreciable affect on glutamate.

Then foolishly and in a moment of complete mental collapse I came to CafePharma.
And after totally pissing away 30 min of my life reading these posts let me ask all you conspiracy theorists and excessively “talented” folks a question:

What do you think would happen to the company (leadership, board, investors, stakeholders, etc) if ANY of your theories got out and the launch of the companies flagship molecule was botched?

Take your time. It’s a thinker....

You only get one chance to launch a drug, especially for a disease state as small as schizophrenia. So, the market will overreact when they miss expectations and they will be an easier target for an acquisition. The board will get antsy, not trust the leadership, and push to sell.

 

[anonymous]

You only get one chance to launch a drug, especially for a disease state as small as schizophrenia. So, the market will overreact when they miss expectations and they will be an easier target for an acquisition. The board will get antsy, not trust the leadership, and push to sell.

correct.

and all because the car choices weren’t acceptable??? Really????

I think not

 

[anonymous]

If you think you’re worth more, then go be the rockstar you think you are and force them to pay you.
Otherwise why would anyone overpay for something you haven’t done yet?

They're writing the check. Not you

 

[anonymous]

correct.

and all because the car choices weren’t acceptable??? Really????

I think not

Hilarious! Especially love the “mental collapse”. Couldn’t describe cafepharma any better. And yet here I am LOL

 

[anonymous]

Think about this drug for a minute. It’s an atypical that has a schizophrenia indication. It has less EPS, at least in the studies. It works on glutamate. It’s a little different. It will compete in a market that’s 97%+ generic. How profitable will it be for the company with the rebates they will have to pay for coverage, and the cost of doing business? What effect will future government regulations have on it, and other brand drugs? Is it really that much better, and will the docs see the amazing superiority of it vs competitors? In rural areas, the CMHC’s will be the targets because a lot of psychs just don’t treat schizophrenia anymore and ship them off, especially in poor areas. The CMHC’s are under tremendous pressure to lower their costs, and their patients are mostly Medicaid.

It is very much possible that this drug will be viewed as just another atypical that’s a little better for schizophrenia, but nobody can get it because of lack of managed care coverage. Time will tell.

 

[anonymous]

correct.

and all because the car choices weren’t acceptable??? Really????

I think not

I don’t think we are all referencing the cars here. I don’t care about the car. But the low ball offer, no negotiations, and people accepting offers who have no intent on going through the whole launch.

 

[anonymous]

correct.

and all because the car choices weren’t acceptable??? Really????

I think not

You aren't replying to me but I believe you are missing the perrson's point. It's not just the cars, it's the possibly less salary than discussed with recruiter, no salary negotiation, no flexibility or discussion regarding pay or anything left behind, etc. How many top performers are going to jump ship for little to no extra salary, leave behind big bonuses, downgrade vehicles, miss out on 401k contributions for 6 months, etc for some potential upside of company stock? I don't believe many. For us who started in the process many months ago the wanting to attract top talent and creating a valued employees culture has changed as time has gone on. That's my feeling anyway, but all my colleagues around the country feel the same. Many no longer considering or no hesitant to start.

 

[anonymous]

Think about this drug for a minute. It’s an atypical that has a schizophrenia indication. It has less EPS, at least in the studies. It works on glutamate. It’s a little different. It will compete in a market that’s 97%+ generic. How profitable will it be for the company with the rebates they will have to pay for coverage, and the cost of doing business? What effect will future government regulations have on it, and other brand drugs? Is it really that much better, and will the docs see the amazing superiority of it vs competitors? In rural areas, the CMHC’s will be the targets because a lot of psychs just don’t treat schizophrenia anymore and ship them off, especially in poor areas. The CMHC’s are under tremendous pressure to lower their costs, and their patients are mostly Medicaid.

It is very much possible that this drug will be viewed as just another atypical that’s a little better for schizophrenia, but nobody can get it because of lack of managed care coverage. Time will tell.

I think this molecule has some real merit and can make some pretty big moves considering the crowded generic market with the right person selling it. This is truly a salespersons drug, you get providers to understand the value of the new MOA and what it means for their patients and it should move, as long as it works real world. Having the right rep will make a difference here.

Schizophrenia will be a tough launch in many geographies because of institutional access to the patient population though.

 

[anonymous]

You aren't replying to me but I believe you are missing the perrson's point. It's not just the cars, it's the possibly less salary than discussed with recruiter, no salary negotiation, no flexibility or discussion regarding pay or anything left behind, etc. How many top performers are going to jump ship for little to no extra salary, leave behind big bonuses, downgrade vehicles, miss out on 401k contributions for 6 months, etc for some potential upside of company stock? I don't believe many. For us who started in the process many months ago the wanting to attract top talent and creating a valued employees culture has changed as time has gone on. That's my feeling anyway, but all my colleagues around the country feel the same. Many no longer considering or no hesitant to start.

I believe that about sums it up.

 

[anonymous]

You aren't replying to me but I believe you are missing the perrson's point. It's not just the cars, it's the possibly less salary than discussed with recruiter, no salary negotiation, no flexibility or discussion regarding pay or anything left behind, etc. How many top performers are going to jump ship for little to no extra salary, leave behind big bonuses, downgrade vehicles, miss out on 401k contributions for 6 months, etc for some potential upside of company stock? I don't believe many. For us who started in the process many months ago the wanting to attract top talent and creating a valued employees culture has changed as time has gone on. That's my feeling anyway, but all my colleagues around the country feel the same. Many no longer considering or no hesitant to start.

Then move on.
Seems to be an awful lot of concern about a company all you high performers should not be concerned with.

 

[anonymous]

Recruiter is frustrated. Some regionals doing interviews for districts where managers don't start until January. Some are not. WTF?

This "recruiting" company is a dumpster fire and the cause of the frustration. Internally alarms are now going off about the issues and limitations, all they did was push candidates that they have placed 1, 2, and even 3 times previously and then sold them to us as "the best in ______(given location)". When the resume is average or poor there was probably no "recruiting" happening there ExSalesPros, we mean RxSalesPros

 

[anonymous]

Then move on.
Seems to be an awful lot of concern about a company all you high performers should not be concerned with.

Most are